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Abstract
Background: Dietary salt reduction is included in the top five priority actions for non-communicable disease
control internationally. We therefore aimed to identify health gain and cost impacts of achieving a national target
for sodium reduction, along with component targets in different food groups.
Methods: We used an established dietary sodium intervention model to study 10 interventions to achieve sodium
reduction targets. The 2011 New Zealand (NZ) adult population (2.3 million aged 35+ years) was simulated over the
remainder of their lifetime in a Markov model with a 3 % discount rate.
Results: Achieving an overall 35 % reduction in dietary salt intake via implementation of mandatory maximum
levels of sodium in packaged foods along with reduced sodium from fast foods/restaurant food and discretionary
intake (the “full target”), was estimated to gain 235,000 QALYs over the lifetime of the cohort (95 % uncertainty
interval [UI]: 176,000 to 298,000). For specific target components the range was from 122,000 QALYs gained (for the
packaged foods target) down to the snack foods target (6100 QALYs; and representing a 34–48 % sodium reduction in
such products).
All ten target interventions studied were cost-saving, with the greatest costs saved for the mandatory “full target” at
NZ$1260 million (US$820 million). There were relatively greater health gains per adult for men and for Māori
(indigenous population).
Conclusions: This work provides modeling-level evidence that achieving dietary sodium reduction targets (including
specific food category targets) could generate large health gains and cost savings for a national health sector.
Demographic groups with the highest cardiovascular disease rates stand to gain most, assisting in reducing health
inequalities between sex and ethnic groups.
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Background
A diet high in sodium is ranked as the second most im-
portant dietary risk factor to health globally [1] and salt
reduction is included in the top five priority actions for
non-communicable disease (NCD) control internation-
ally [2]. The World Health Organization (WHO) has a
“strong recommendation” for countries to aim for a
30 % relative reduction in dietary intakes towards 5 g/
day of salt [3].
While there are some persisting concerns around the
relationship between dietary salt intake and health out-
comes, the totality of the evidence is likely to justify
public health action (as some of us have discussed else-
where [4]). There are also several recent publications
that add further weight to the adverse impact of dietary
salt on health [5–10]. Even when the theoretical mini-
mum level of risk exposure of sodium intake is modeled
with wide uncertainty (from 1000 to 5000 mg of dietary
sodium per day), it resulted in dietary sodium being
ranked as the 11th most important risk factor to health
globally in the Global Burden of Disease 2013 Study [1].
There are now a number of modeling studies which
have considered the health gain and/or economic
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aspects of dietary sodium reduction with reviews of
these in the published literature [4, 11, 12]. Of these
studies, some have started to consider reductions in sodium
levels in specific targeted foods or food categories (Table 1).
The results of these studies are all favorable in terms of
generating health gain, and some report cost-savings.
Nevertheless, there appears to be little modeling around
evidence-based sodium reduction targets (i.e., that consider
population sodium intakes and feasible reductions), or of
comparing the relative benefits of achieving various food
category specific targets e.g., for bread vs processed meats.
Such information is important given that one of the
approaches recommended by the WHO is food reformu-
lation with “target setting” for food manufacturers [13].
Indeed, 13 European countries have “developed or are in
the process of developing national targets for salt reduc-
tion, covering between one and 80 food categories” [14].
Moreover, some of these countries have already adopted
mandatory targets (as maximal levels) e.g., Belgium,
Bulgaria, Finland, Greece, Hungary, Portugal, and The
Netherlands [14, 15]. There has also been progress
around salt-reduction targets by nations in South
Table 1 Health impact and health economic modeling studies of population-level dietary salt reduction interventions involving reductions
in sodium in processed foods (for publications from 1 January 2010 up to the end of June 2015 and ordered by publication year)
Setting and reference Interventions aimed at specific foods/food categories Main results/comment
Australia, Cobiac et al
2010 [47]
Voluntary and mandatory reduction of salt content in
breads, margarine, and cereals.
Both were cost-saving interventions but health gain was
much greater for the mandatory vs voluntary intervention
(e.g., 110,000 vs 5300 disability-adjusted life-years [DALYs]
averted).
US, Smith-Spangler et al
2010 [48]
Voluntary collaboration with industry was assumed to
decrease sodium intake by the same amount as
reported for the UK (9.5 %), with a range of 5 to 40 %.
Large health gain of 2.1 million QALYs, and savings in
medical costs of $US32.1 billion (both over the cohort’s
lifetime). Large benefits were seen with a salt tax.
Argentina, Rubinstein et al
2010 [49]
Voluntary reduction of salt content in bread by 1 g salt
per 100 g.
Relatively small averted DALYs (compared to other CVD
interventions) but still a cost-saving intervention. An earlier
result by this team identified this intervention as
cost-effective at ARS$151 (US$28) per DALY averted [50].
South Africa, Bertram et al
2012 [51]
Regulations to reduce the sodium content of bread,
soup mix, seasoning and margarine (a reduction in
salt of 0.85 g/person/day).
Substantial reduction in CVD deaths and non-fatal strokes
estimated. Cost savings “of up to R300 million would also
occur” (US$128 million).
Australia, Cobiac et al
2012 [52]
Mandatory reduction of salt content in breads,
margarine, and cereals.
Large number of DALYs averted per year (80,000) and
cost-saving. (See also a similar study listed above by these
authors).
Argentina, Konfino et al
2013 [53]
Voluntary initiative currently in place in Argentina for 5
to 15 % reductions of sodium in: (i) processed meats,
(ii) cheese and dairy products, (iii) soups and dressings
and (iv) cereals, cookies, pizza and pasta.
Large reductions in: all-cause mortality, myocardial
infarctions, and strokes, especially if the 2 year program
agreed to with industry was extended to a larger 10 year
one. (But no cost data included).
Netherlands, Hendriksen
et al 2014 [54]
Theoretical reduction in salt in processed foods (variable
by food category – but averaging 50 % reduction).
The median salt intake was expected to decrease by 28 %
and blood pressure by 1.2 %. An estimated 256,000 DALYs
were averted (239,700 to 272,300) and 0.15 per capita life
years gained (0.11–0.19) among 40 year olds over the rest
of their lifetimes.
New Zealand, Nghiem et al
2015 [4]
Mandatory 25 % reduction of salt in bread, processed
meats and sauces. Also a voluntary endorsement label
program (covering heart healthy foods [55]).
The gain was larger in the mandatory intervention (62,000
quality-adjusted life-years [QALYs]) vs the current voluntary
endorsement label program (8000 QALYs). The interventions
were pro-equity with relatively greater health gain for
indigenous people (Māori).
USA, Choi et al 2015 [38] Expansion of the National Salt Reduction Initiative to
ensure all restaurants and manufacturers reach agreed
upon sodium targets. These cut sodium in 62 categories
of packaged, and 25 categories of restaurant, food items.
This expansion “would be expected to avert from 0.9 to 3.0
MIs [myocardial infarctions] (a 1.6–5.4 % reduction) and 0.5
to 2.8 strokes (a 1.1–6.2 % reduction) per 10,000 Americans
per year over the next decade.” Most of the benefit came
from changes in packaged foods. Also that “even high
levels of consumer addition of table salt or substitution
among food categories would be unlikely to neutralize this
benefit”. The intervention was not found to reduce ethnic
inequalities. No cost data were included.
England, Gillespie et al
2015 [56]
Mandatory reductions in all processed foods (10 %
and 30 %). Voluntary reformation (24 %) – based on
expert panel.
By the year 2025, maximum life-years gained by the
mandatory reductions: at 43,900 for the 30 % and 14,800 for
the 10 % levels. For voluntary: 14,300 life-years gained. The
benefit in reducing health inequalities was greater for the
mandatory than the voluntary interventions (when
considering absolute differences in life-years).
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America [16] and for South Africa [17]. Some of the best
evidence for the benefit of reducing sodium levels in
processed foods comes from the UK where sodium re-
duction targets, as part of a national sodium reduction
strategy, have resulted in reduced sodium intakes at the
population level [18–20].
Given this picture, we aimed to build on our previous
modeling work [4] to estimate with uncertainty the
health gain and cost-effectiveness of a country achieving
the reduction recommended by WHO for dietary sodium
intake, and also for the specific food category target
components.
Methods
Model structure and perspective
The model was a Markov macro-simulation model in
TreeAge Pro version 2013, from which we have previously
published modeling interventions [4]. The simulated
population was a closed cohort of the New Zealand popu-
lation aged 35 years and older (2.3 million people), mod-
eled from the baseline year (2011). The Markov model has
four primary health states, with annual transition rates
capturing incidence and case-fatality for coronary heart
disease (CHD) and stroke events (see the diagram in an
online Technical Report [21] on the BODE3 website;
www.otago.ac.nz/bode3). The simulated population move
through these health states until death or age 100 years,
with the modeled intervention changing the annual transi-
tion probabilities of the population moving into these
health states.
In terms of modeling background disease trends we
took the same approach as the New Zealand Burden of
Disease Study (NZBDS) [22], and assumed a continued
decline in incidence rates for both CHD and stroke of
2.0 % annually, and also a 2.0 % reduction in case-
fatality annually i.e., reflecting improved treatment and
management. We extended this projection from 2016
(NZBDS end estimate) to the year 2026 and then held
the incidence and case-fatality rates constant. Back-
ground population mortality was assumed to decline at
a somewhat lower rate than for CVD with a 1.75 % an-
nual reduction for non-Māori, and 2.25 % for the indi-
genous population of Māori (also out to the year 2026),
then 0 % per annum decline for both ethnic groupings
thereafter (for justification see: [23, 24]).
A health system perspective was used and costs and
benefits beyond the health system (e.g., productivity
gains from preventing premature deaths of workers) were
considered out of scope. However, additional health sys-
tem costs arising from extra life expectancy in the future
attributable to the impact of the modeled interventions
were included in the baseline analyses. Costs were calcu-
lated in 2011 New Zealand dollars and a 3 % discount rate
was applied to costs and future health gain.
All interventions were evaluated against a theoretical
“do nothing” comparator as per typical modeling practice
[25]. This required us to remove the impact of the existing
sodium reduction interventions in place in New Zealand
of dietary counselling by dietitians and an endorsement
food labeling program run by the Heart Foundation [4].
However, both of these interventions have relatively little
impact on sodium intakes, and thus the analysis is fairly
similar to a comparison with “current practice”.
Input parameters
These parameters are summarized in the text below with
additional details shown in Table A, Table B and Table C
in Additional file 1.
Incidence, prevalence and case-fatality
The estimated incidence, prevalence and case-fatality
rates of CHD and stroke (ischemic and hemorrhagic)
were calculated across all combinations of sex, 5 year
age-groups (35–39, 40–44, … 95+ years) and ethnicity
(Māori; and non-Māori). Data came from ‘Health
Tracker’, which is a collection of linked administrative
datasets of publically-funded health system events man-
aged by the Ministry of Health [26]. Health Tracker in-
cludes hospitalizations, mortality, cancer registrations,
mental health and addiction service use, pharmaceutical
and laboratory claims, primary health care enrolment,
and outpatient/emergency department visits for the en-
tire New Zealand population with costs attached.
Validation of model parameters and the final model
outputs (relative to two official data sources) are detailed
in an online Validation Report [27]. This additional work
also involved parameter coherence checking using the
epidemiological software program DisMod II [28].
Subsequently, we also conducted a model validation
exercise by comparing our TreeAge model with a multi-
state life-table model, similar to the one used in a tobacco
tax modeling study [29]. For the same sodium reduction
intervention of a 22.8 mmol/day reduction in dietary in-
take (as used in our previous modeling [4]), the overall
QALYs gained were 110,000 in our TreeAge model and
103,000 in the multi-state life-table model (both with 3 %
discounting). We regarded this 6 % difference in results as
acceptable given the models differed slightly in aspects of
model structure and in baseline disease incidence rates
and baseline case-fatality rates.
Morbidity and disability weights
Overall morbidity, by sex, age and ethnicity, was quanti-
fied in the model using the years of life lived with disability
(YLDs) from the NZBDS [22], divided by the population
count to give ‘prevalent’ YLDs. Disease-specific morbidity
was assigned in each disease state (e.g., CHD and stroke),
as the total comorbidity-adjusted YLDs for that disease
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divided by the prevalent population. The health status
valuation used to calculate these YLDs were disability
weights (DW) derived from the Global Burden of Disease
study (GBD2010) using pair-wise comparisons from
multi-country surveys [30] (e.g., as opposed to using dis-
utilities from the EuroQol). These DWs are on a scale
from 0 (full health) to 1.0 (death) and include uncertainty
(for details see the online Technical Report [21]). The
quality-adjusted life-years (QALYs) were then cumula-
tively tallied for the life-span of the modeled cohort.
Intervention specification
The “full target” and component food category targets
were based on an evidence-based New Zealand salt
reduction “target model”. Specific details of this work
are in Table A in Additional file 1 and a thesis available
online [31]. In brief, this “target model” involved estimat-
ing the sources of sodium in the typical New Zealand
adult diet from a combination of market research com-
pany data on food purchases (electronically scanned by a
consumer panel) and “Nutritrack” data for the brand-
specific nutritional composition of packaged foods avail-
able in New Zealand supermarkets [32]. Salt consumed at
home and in other foods away from the home was esti-
mated from both National Nutrition Survey data [33], and
US data [34]. Reductions in sodium in various food cat-
egories were partly informed by the UK Salt Reduction
Targets for 2017, which had benefited from extensive con-
sultation with the food industry [35]. The “full target” was
a 35 % reduction in dietary salt (from 8.4 g to 5.5 g), to en-
sure an extra margin of success in meeting the WHO
country recommendation of a 30 % relative reduction to-
wards 5 g/day [3].
The interventions modeled are outlined in Table 2.
For each of these we modeled either mandatory regula-
tions requiring lower maximum levels of sodium in
foods, or voluntary reductions. The latter had longer
phase-in periods (5 vs 3 years) and more uncertainty
around the impact (Table B, Table C in Additional file 1).
Costing of intervention scenarios and health system costs
We considered the net cost, which is the intervention
costs plus health system costs throughout the lifespan of
the modeled cohort (i.e., the results captured additional
health costs associated with any extra lifespan generated
by the interventions). Specific details for the costing of
the interventions are provided in Table C in Additional
file 1. For health system costs, the ‘business-as-usual’
ones were determined by strata of sex and age using
Health Tracker data, which links cost estimates to all
Table 2 Full target and component food category sodium reduction targets modeled
Intervention Sodium reduction target details
1) Full target achieved (i.e., 35 % relative reduction to 5.5 g/d of salt) via
packaged food target, fast food target and reduced discretionary use
The Intervention 2 target on all packaged foods (36 % reduction in
sodium), plus the Intervention 3 target on fast food/restaurant meals (40 %
reduction), plus discretionary use reduction (40 % reduction) but no
changes to other foods. Overall there was a 35 % reduction.
2) Packaged foods target achieved The specific targets for all packaged foods – including those packaged
foods in this table and others in the full model [31] (a 36 % reduction in
sodium in these foods overall).
3) Fast food and restaurant target achieved An overall reduction of 40 % in sodium in these foods.
4) Bread target achieveda Targets ranged from a 12 % reduction in wholemeal bread to a 37 %
reduction in “other bread”. The most common target was to reduce to
350 mg sodium per 100 g of bread. A systematic review has indicated that
salt can be reduced by approximately 40 % in breads [57].
5) Processed meats target achieveda Targets ranged from a 35 % reduction in “cured meats” to a 55 % reduction
in “other meat products” (covering all categories except for “raw” and
“frozen” meat). A systematic review has indicated that salt can be reduced
by approximately 70 % in processed meats [57].
6) Sauces target achieveda Targets ranged from a 30 % reduction in marinades to a 63 % reduction in
“powdered mixes for meal-based sauces”.
7) Package of Interventions 4 to 6 The combined (fully additive) effect of achieving the targets for bread,
processed meats, and sauces collectively (the top three contributors to
dietary sodium).
8) Snack food target achieveda Targets ranged from a 34 % reduction in “extruded snacks” to a 48 %
reduction in “potato chips”.
9) All bread and bakery target achieveda As per Intervention 4 but with all other bakery products added (54 %
reduction in “sweet biscuits” and 63 % reduction in “cakes, muffins and
pastries”).
10) Cheese target achieveda Targets ranged from a 27 % reduction in “hard block cheese” to a 42 %
reduction in “soft/fresh cheese”.
a This specific intervention was a component of Intervention 2, which in turn contributed to the “full target” in Intervention 1
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health events. From this dataset we calculated the 2011
costs for the first year of CHD and stroke, and then the
average annual cost for the second and subsequent years.
Furthermore, given that CVD is a relatively important
part of baseline health system costs, we adjusted the
baseline health system costs experienced by the “healthy”
component of the modeled population, to remove the
CVD-attributable cost component (to avoid double-
counting).
Of note is that gaps in Health Tracker data exist in
specific areas (e.g., some private sector expenditure and
the health-related aspects of residential care [26]) and so
we scaled up both the CVD disease costs and the annual
health system costs for the non-diseased population. For
the disease costs we scaled up Health Tracker costs
across all age groups by 1.2, given that 83 % of all health
spending in New Zealand is public (i.e., 1/0.83 = 1.2). Fi-
nally, costs at older ages were multiplied by 1.1, 1.2, 1.3
for the 65–74, 75–84 and 85+ age groups respectively to
capture the estimated missing data of residential ‘disabil-
ity support services’ care funded through government
(‘Vote:Health’) but not yet captured in available data. All
costs included those in the last 6 months of life.
Analysis
For each of the interventions a reduction in dietary so-
dium intake was linked to a reduction in systolic blood
pressure (BP) based on values derived from the regression
models developed by Law et al [36] (see Table A in
Additional file 1 for details). A reduction in systolic
BP was then linked to a reduced probability of adverse
health outcomes (CHD and stroke) as per a meta-analysis
of 61 prospective studies by Lewington et al [37]. From
this we generated QALYs gained and changes in health
costs (from reduced disease burden and increased life ex-
pectancy). Analyses were by sex, ethnicity, and age-group.
We reran models (usually for expected values only) for
a range of scenarios to assess the impact of components
of the interventions and other structural assumptions
(e.g., the discount rate: at 0 and 6 %). As an additional
scenario analysis for the voluntary interventions, we
modeled an effect size that was half of the baseline
values to account for plausible non-compliance with the
food category targets.
Results
The largest health gains were for achieving the “full tar-
get” with the mandatory approach (i.e., a 35 % relative
reduction down to 5.5 g salt per day from reductions in
packaged foods, and from fast food/restaurant foods,
and from reduced discretionary use). That is, 235,000
QALYs gained over the lifetime of the modeled cohort
(95 % uncertainty interval [UI]: 176,000 to 298,000; or a
0.7 % increase in lifetime QALYs for the 2011 cohort, i.e.
235,000/33.2 million) (Tables 3 and 4, Fig. 1). The results
for the mandatory target were 6 % higher than for when
this same target was achieved via a voluntary approach
(at 222,000 QALYs gained). The health gain of various
components of the full package in descending order and
regardless of the mandatory or voluntary nature, was for
achieving targets for: packaged foods; fast foods and res-
taurant meals; bread, sauces and processed meats com-
bined; bread and bakery products; sauces; processed
meats; bread; cheese; and snack food (the latter at 6100
QALYs for the mandatory approach).
Costs were strongly and linearly associated with
QALYs, as the intervention costs were usually small
meaning that avoided future health system costs were
vastly more important, and reduced disease incidence
co-generates QALY gains and reduced health system
costs. All interventions were cost-saving (Table 3), with
this being highest for the mandatory approach to the full
target at $1260 million saved over the lifetime of the
modeled cohort (compared to $1170 million for the full
target via the voluntary approach). A cost-effectiveness
plane in Fig. 1 shows results, with uncertainty, for a
range of the mandatory interventions.
For all interventions, the health gains were greater for
mandatory compared with voluntary approaches. The
benefit was also greater per capita for men and for
Māori e.g., 25 % more than non-Māori for the full target
(see examples in Table 4). For all interventions in all
socio-demographic groups, the interventions were also
cost-saving.
The overall cost results were largely driven by averted
disease treatment costs for CVD, followed by the in-
creased health system costs from extra lives lived (as a
result of the interventions) (Table D in Additional file 1).
Scenario analyses
Scenario analyses showed that even with a higher 6 %
discount rate, all interventions (and both mandatory and
voluntary approaches) still produced net health system
cost savings (Table E in Additional file 1). Net cost sav-
ings also occurred when we modeled an effect size that
was half of the baseline values for the voluntary ap-
proach (to account for plausible non-compliance with
the targets, Table F in Additional file 1).
Uncertainty analyses
Tornado plots demonstrate how uncertainty in input
parameters had an impact on the uncertainty in the
model’s outputs (Figure A in Additional file 1 for the
“packaged foods target” intervention). Uncertainty for
costs was particularly driven by the uncertainty in the
level of CHD disease cost (especially for men) and the
effect size of the BP change for CHD risk.
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Table 3 Population level results for the health gain and cost of the 10 sodium reduction interventions (95 % uncertainty intervals) a
Intervention Health gain (QALYs for remainder of the cohort’s life) Health system cost (NZ$; millions) for remainder
of the cohort’s life
“Do nothing” comparator b 33.2 million (33.0 to 33.4 million) 162,000 (145,000 to 181,000)
Incremental to “Do nothing
– Mandatory measures achieved
1) Full target 235,000 (176,000 to 298,000) -1260 (-1710 to 870)
2) Packaged foods target 122,000 (98,200 to 149,000) -660 (-868 to 480)
3) Fast food & restaurant target 68,700 (55,200 to 83,600) -370 (-487 to 270)
4) Bread target 8900 (7100 to 10,800) -45.2 (-61 to 32)
5) Processed meats target 13,400 (10,800 to 16,200) -70.0 (-94 to 50)
6) Sauces target 20,000 (16,100 to 24,300) -106 (-141 to 77)
7) Package of Interventions 4 to 6 42,400 (34,200 to 51,500) -228 (-302 to 167)
8) Snack food target 6100 (5000 to 7400) -30.3 (-40 to 21)
9) All bread and bakery target 20,400 (16,600 to 24,800) -108 (-141 to 78)
10) Cheese target 8800 (7100 to 10,600) -44.6 (-59 to 32)
– Voluntary measures achieved
1) Full target 222,000 (168,000 to 284,000) -1170 (-1600 to 798)
2) Packaged foods target 115,000 (85,300 to 147,000) -608 (-827 to 425)
3) Fast food & restaurant target 64,700 (48,000 to 82,200) -338 (-461 to 236)
4) Bread target 8400 (6200 to 10,600) -35.7 (-52 to 22)
5) Processed meats target 12,700 (9600 to 16,000) -58.4 (-82 to 38)
6) Sauces target 18,900 (14,400 to 23,900) -91.9 (-128 to 61)
7) Package of Interventions 4 to 6 40,100 (30,500 to 50,700) -205 (-281 to 141)
8) Snack food target 5800 (4400 to 7300) -22.0 (-34 to 12)
9) All bread and bakery target 19,400 (14,700 to 24,400) -95.1 (-134 to 63)
10) Cheese target 8300 (6300 to 10,500) -35.4 (-52 to 22)
a Expected values for the NZ adult population aged 35+ years and alive in 2011 modeled out to death or age 100. Numbers are rounded to two or three
meaningful digits
b No intervention costs are included in this “do nothing comparator” (i.e., the costs of the currently existing programs of “dietary counselling by dietitians” and the
“Endorsement Label Program” [4] are removed)
Table 4 Net health gain and costs incremental to “do nothing” by socio-demographic group for selecteda sodium reduction interventions
(expressed per adult in 2011, over the remainder of their life with 3 % discounting)
Full target (mandatory) Packaged foods target
(mandatory)

























Age < 65 yearsb 0.112 -$689 0.059 -$362 0.033 -$203 0.0029 -$16.9
Age 65+ yearsb 0.072 -$127 0.037 -$66 0.021 -$36.6 0.0019 -$2.2
Women 0.085 -$423 0.044 -$222 0.025 -$125 0.0022 -$9.9
Men 0.121 -$680 0.063 -$357 0.035 -$200 0.0032 -$16.8
Māori 0.130 -$461 0.068 -$242 0.038 -$136 0.0034 -$11.0
Non-Māori 0.099 -$555 0.051 -$291 0.029 -$163 0.0026 -$13.4
a Interventions selected to show the three highest impact ones and also the lowest impact one (for the mandatory range of interventions)
b This is the starting age-group, with the results for the rest of the lives in these modeled populations
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For QALY gains, the most important drivers of mod-
eled uncertainty were the extent of the sodium reduction
(especially in men) and the effect size of the BP change
for CHD risk and stroke risk.
Discussion
Main findings and interpretation
This study adds to the existing modeling-level evidence
that interventions for reducing dietary sodium have the
potential to generate large health gains and also large
cost-savings for a health system. It suggests that there
are large differences in the health and cost impact of the
different specific targets, along with notable levels of un-
certainty. Of the specific components of the full target
intervention, it would seem the priority ones for maxi-
mizing health gain are the categories of “all packaged
foods”, and then “fast foods and restaurant meals”
(achieving 52 and 29 % of the health gain of the full tar-
get respectively). This pattern is similar to that found in
a US modeling study [38].
Although these interventions based on reformulation
are promising, other salt reduction interventions using
the same model produce even larger health gain and
greater cost savings: a sinking lid on the supply of salt
and a salt tax [4]. Indeed, such salt reduction interven-
tions may produce even greater health gains than regular
increases in tobacco tax – at least for New Zealand [29].
However, reformulation interventions are particularly
important to study because they may be more politically
acceptable than other measures.
Mandatory approaches to achieving the targets were
estimated to generate more health gain and be more
cost-effective than voluntary ones. This pattern has been
reported by others (see studies in Table 1 for Australia,
England and New Zealand). Nevertheless, such differ-
ences may partly reflect various assumptions around
intervention phase-in periods and intervention costs.
All interventions modeled were cost-saving and health
inequality reducing as they generated greater QALY
gains per adult for both the indigenous Māori popula-
tion and men. This inequality reduction is similar to our
previous work [4], and it reflects higher background
CVD rates in Māori so that there is more potential for
health gain from reducing blood pressure in Māori
(there are minimal differences in sodium intakes between
Māori and non-Māori). In contrast, no such pattern of in-
equality reduction by ethnic group has been reported for a
salt-reduction intervention in the USA [38].
The collective results of this modeling work will prob-
ably have a reasonable applicability to other developed
countries since high sodium intakes are common and a
major risk to health internationally [1]. Nevertheless, the
impact on health inequalities may vary between coun-
tries depending on population groups, background CVD
risk, intake of processed foods, and genetic variation in
salt sensitivity [39]. Countries can also differ in the levels
of sodium in processed food [40]. Nonetheless, even with
diverse food cultures in Europe, many of the countries are
targeting similar types of food for salt reduction [14].
Study strengths and limitations
This study built on previous New Zealand and Australian
modeling work to explore a wide range of food category
specific salt-reduction interventions. It appears to be only
the second such modeling paper to consider such a large
range of food categories (after Choi et al [38]) and also
Fig. 1 Cost-effectiveness plane for interventions that achieve selected mandatory sodium reduction targets for the New Zealand adult population
(selected targets to show the full range of results)
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one of the few to use targets based on an evidence-based
dietary salt reduction target model or specifically compare
voluntary and mandatory approaches. The modeling work
also benefited from relatively high quality cost and ethni-
city data.
Nevertheless, there are limitations with all modeling
studies, especially in comparison with well-designed ex-
perimental studies (although the latter are sometimes
not possible for national-level policy interventions). As
noted previously [4], there are also specific limitations
with this sodium modeling work that should make
policy-makers cautious in how they use any particular
results. In summary these limitations include:
 Issues with model structure; and indeed our
uncertainty estimates do not capture uncertainty
arising from “model structure uncertainty”. For
example, this model did not capture potential
benefits of salt reduction on preventing stomach
cancer [41] and renal disease [42]. Also, any
potential benefits arising from the addition of extra
potassium to processed food were not considered
(as might be expected as per this systematic review
[43] if food manufacturers replaced some sodium
chloride with potassium chloride).
 Limitations around input parameters (e.g.,
particularly relating to the proportion of dietary
sodium coming from fast food and restaurant meals
and assumptions made in missing purchasing data
for the dietary salt reduction target model). There
were also limitations with current Health Tracker
costs and some epidemiological data (e.g., prevalence
of CVD [4]) and we also did not include uncertainty
surrounding the phase-in periods for the interventions.
 Unknowns in how the public and industry might
respond to achieving the targets were not captured.
For example, the food industry might respond by
adding flavor compensating ingredients such as
more sugar, which could off-set some of the health
benefits of sodium reductions (if sugar levels were
also not regulated).
Potential research and policy implications
Given this and other past work (Introduction and
Table 1), the key research issue for most countries is
probably to identify barriers (political and otherwise) to
implementing various dietary salt reduction measures. If
these barriers are considerable, then policy-makers could
start with less ambitious reductions (but ideally still
mandatory ones) via maximum sodium limits on various
packaged foods. Or they could focus first on high so-
dium foods that can be considered to be non-essential
(e.g., snack foods) or which have other health risks (e.g.,
the cancer risk from processed meats [44]). One way to
potentially gain public support would be to combine the
use of salt reduction targets with improvements in nutri-
ent labeling and conducting mass media campaigns on
the health hazard of high sodium diets. Finally, one way
that stricter salt reduction targets might be more easily
achieved is to encourage the food industry to use potas-
sium salts as substitutes for sodium chloride (as used in
Finland [45]).
Policy-makers who remain skeptical of the scientific
basis for dietary sodium reduction and of the results of
modeling studies have such choices as waiting for more
evidence from experimental studies (e.g., a large trial un-
derway in China [46]). Or they could focus on broader
dietary interventions that may reduce the intake of diet-
ary energy and free sugars as well as sodium (e.g., a
Mexico-style “junk food” tax). Also if they wish to just
focus on reducing the very high dietary intakes of so-
dium that virtually all researchers agree are hazardous
(above 5000 mg sodium per day as per the Global
Burden of Disease 2013 Study [1]), then they could
target products that may particularly contribute to
such high intakes (e.g., high sodium sauces).
Conclusions
This work provides modeling-level evidence that achiev-
ing reduced sodium intakes via food category targets
would generate large health gain and cost savings for the
health sector. The categories of “all packaged foods”,
then “fast foods and restaurant meals” appear to be the
priority categories for achieving the largest health gains.
These interventions may also be pro-equity by achieving
larger per person benefits for men and indigenous
populations.
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